The T84 human colonic adenocarcinoma cell line produces mucin in culture and releases it in response to various secretagogues.
The T84 colonic adenocarcinoma cell line, which has been used extensively as a model for studies of epithelial chloride secretion, also produces mucin and secretes it in culture. Electron microscopy of fixed sections of cultured cells, along with Immunogold labelling with an antibody to human small intestine (SI) mucin, revealed the presence of goblet-like cells with mucin-containing secretory granules. The mucin was of high molecular mass, had an amino acid composition similar to that of purified human SI and colonic mucins, and competed effectively with SI mucin for binding to the anti-(SI mucin) antibody. A sensitive solid-phase immunoassay specific for intestinal mucins was developed and used to measure mucin secretion by T84 cells. Cultures were treated for 30 min at 37 degrees C with a number of agents known to cause chloride secretion by T84 cell monolayers and the amount of mucin appearing in the medium was measured. Carbachol (1 mM), A23187 (10 microM), prostaglandin E1 (PGE1) (1 microM) and vasoactive intestinal polypeptide (VIP) (0.1 microM) all stimulated mucin release, but histamine (1 mM) had no effect. Whereas VIP is reported to stimulate chloride secretion more strongly than carbachol, it was less effective than carbachol in stimulating mucin secretion. Phorbol 12-myristate 13-acetate (PMA) (0.1-10 microM) also stimulated mucin release strongly, implicating a responsive protein-kinase C-dependent pathway. Additive secretory responses were obtained with combined stimulation by VIP (10 nM-1 microM) and carbachol (1 mM). Responses to stimulation with A23187 (1-10 microM) together with PMA (10 nM-10 microM) suggest that cytosolic Ca2+ concentration is a modulator of PMA activity.
McCool
D J
DJ
Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.
Marcon
M A
MA
Forstner
J F
JF
Forstner
G G
GG
D000230:Adenocarcinoma; D000001:Calcimycin / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D002460:Cell Line; D002772:Cholera Toxin / Q000494:pharmacology; D003110:Colonic Neoplasms; D003550:Cystic Fibrosis / Q000378:metabolism; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D005779:Immunodiffusion; D007124:Immunoenzyme Techniques; D007421:Intestine, Small / Q000378:metabolism; D008854:Microscopy, Electron; D009077:Mucins / Q000096:biosynthesis* / Q000302:isolation & purification / Q000378:metabolism; D011453:Prostaglandins / Q000494:pharmacology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology
D009077:Mucins; D011453:Prostaglandins; D014660:Vasoactive Intestinal Peptide; D000001:Calcimycin; D006632:Histamine; D002217:Carbachol; D002772:Cholera Toxin; D013755:Tetradecanoylphorbol Acetate